Effects of an acetone extract of Boswellia carterii Birdw. (Burseraceae) gum resin on rats with persistent inflammation

Journal of Alternative and Complementary Medicine

Volumn 11, Issue 2, 2005, Pages 323-331

  Fan, Arthur Yin ^a   Lao, Lixing ^a   Zhang, Rui Xin ^a   Wang, Lin Bo ^a   Lee, David Y W ^b   Ma, Zhong Ze ^b   Zhang, Wu Yan ^b   Berman, Brian ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b MCLEAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETONE; BOSWELLIA CARTERII EXTRACT; GUM RESIN; PLANT EXTRACT; PROTEIN FOS; RESIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BURSERACEAE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; MALE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; BOSWELLIA; FREUND'S ADJUVANT; HYPERALGESIA; MALE; NEUROGENIC INFLAMMATION; PAIN THRESHOLD; PHYTOTHERAPY; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-FOS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; TIME FACTORS;

EID: 18444405580     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2005.11.323     Document Type: Article

References (56)

1. American College of Rheumatology Ad Hoc Committee. Guidelines for the management of rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996;39:713-722.
2. Badria FA, Mikhaeil BR, Maatooq GT, Amer MM. Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood. Z Naturforsch 2003;58:505-516.
3. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data 2004;343:1-19.
4. Bausell RB, Li YF. Power Analysis for Experimental Research: A Practical Guide for the Biological, Medical, and Social Sciences. Cambridge: Cambridge University Press, 2002.
5. Bensky D, Barolet R. Chinese Herbal Medicine: Formulas & Strategies. Seattle: Eastland Press, 1990.
6. Bensky D, Gamble A. Chinese Herbal Medicine: Materia Medica, revised edition. Seattle: Eastland Press, 1993.
7. Buffum M, Buffum JC. Nonsteroidal anti-inflammatory drugs in the elderly. Pain Manag Nurs 2000;1:40-50.
8. Bullitt E. Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat. J Comp Neurol 1990;296:517-530.
9. Cao H, Wang ST, Wu LY, Wang XT, Jiang AP. Pharmacological study on Tianxiong (Tuber of Aconitum carmichaeli Debx.), a Chinese drug for reinforcing the Kidney Yang retail in Hong Kong Market. Chin J Chin Materia Medica 2001;26:369-372.
10. 2 cytokines in vitro. Presentation at Experimental Biology Meeting, April 2002, New Orleans, LA.
11. Dai Y, Miki K, Fukuoka T, Tokunaga A, Tachibana T, Kondo E, Noguchi K. Suppression of neuropeptides' mRNA expression by herbal medicines in a rat model of peripheral inflammation. Life Sci 2000;66:19-29.
12. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, Kessler RC. Trends in alternative medicine use in the United States, 1990-1997: Results of a follow-up national survey. JAMA 1998;280:1569-1575.
13. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397.
14. Firestein G. Etiology, and pathogenesis of rheumatoid arthritis. In Kelley WN, Harris ED, Ruddy S, Sledge CB (eds.) Textbook of Rheumatology, 5th ed. Philadelphia: W.B. Saunders, 1997:851.
15. Food and Drug Administration. Guidance for Industry Botanical Drug Products. Available at: www.fda.gov/cder/guidance/4592fnl.htm, accessed January 9, 2005.
16. Foster DF, Phillips RS, Hamel MB, Eisenberg DM. Alternative medicine use in older Americans. J Am Geriatr Soc 2000;48:1560-1565.
17. Gad SC. Drug Safety Evaluation. New York: Wiley-Interscience, 2002:131-504.
18. Hargreaves K, Dubner R, Brown F, Flores C, Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988;32:77-88.
19. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987;328:632-634.
20. International Plant Name Index Query. Available at: www.ipni.org/ipni/ query_ipni.html, accessed January 9, 2004.
21. Jing Y, Nakajo S, Xia L, Nakaya K, Fang Q, Waxman S, Han R. Boswellic acid acetate induces differentiation and apoptosis in leukemia cell lines. Leuk Res 1999;23:43-50.
22. Jing YK, Han R. Combination induction of cell differentiation of HL-60 cells by daidzein (S86019) and BC-4 or Ara-C. Yao Xue XueBao 1993;28:11-16.
23. Lao L, Zhang G, Wei F, Berman BM, Ren K. Electro-acupuncture attenuates behavioral hyperalgesia and selectively reduces spinal Fos protein expression in rats with persistent inflammation. J Pain 2001;2:111-117.
24. Liu X, Qi ZH. Experimental study on Jurkat cell apoptosis induced by Boswellia carterii Birdw extractive. Hunan Yi Ke Da Xue Xue Bao 2000;25:241-244.
25. Matthews HB, Lucier GW, Fisher KD. Medicinal herbs in the United States: Research needs. Environ Health Perspect 1999;107:773-778.
26. McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Products Association's Botanical Safety Handbook. New York: CRC Press, 1997.
27. Palm O, Moum B, Jahnsen J, Gran JT. Fibromyalgia and chronic widespread pain in patients with inflammatory bowel disease: A cross sectional population survey. J Rheumatol 2001;28:590-594.
28. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993;19:123-151.
29. Pomp E. A critical evaluation of side effect data on COX-2 inhibitors. Tidsskr Nor Laegeforen 2002;122:476-480.
30. Qu LS, Song JY, Fang YZ. Suppressing effects of longxiangsan on central nervous system. Zhong Cao Yao 1997:28:474-476.
31. Ren K, Ruda MA. Descending modulation of Fos expression after persistent peripheral inflammation. Neuroreport 1996;7:2186-2190.
32. Safayhi H, Boden SE, Schweizer S, Ammon HP. Concentration-dependent potentiating and inhibitory effects of Boswellia extracts on 5-lipoxygenase product formation in stimulated PMNL. Planta Medica 2000;66:110-113.
33. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: Novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992;261:1143-1146.
34. Scheiman JM. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy. Am J Manag Care 2001;7:S10-S14.
35. Sharma, ML, Bani, S, and Singh, GB. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol 1989;11:647.
36. Sharma, ML, Kaul, A, Khajuria, A, Singh, S, and Singh, GB. Immunomodulatory activity of Boswellic Acids (pentacyclic triterpene acids) form Boswellia Serrata. Phytotherapy Res 1996;10:107.
37. Sharma, ML, Khajuria, A, Kaul, A, Singh, S, Singh, GB, and Atal, CK. Effect of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leucocyte migration. Agents Actions 1988;24:161.
38. Shen YJ, Sun RY. The experimental methods of toxicity and safety on Chinese herbal medicine. In: Chen C (ed.) Research Methodology on Pharmacology of Chinese Materia Medica. Beijing: People's Health Press, 2000:117-118.
39. Shin SS, Jin M, Jung HJ, Kim B, Jeon H, Choi JJ, Kim JM, Cho BW, Chung SH, Lee YW, Song YW, Kim SY. Suppressive effect of PG201, an ethanol extract from herbs, on collagen-induced arthritis in mice. Rheumatol 2003;42:665-672.
40. Silverstein FE. Improving the gastrointestinal safety of NSAIDs: The development of misoprostol - from hypothesis to clinical practice. Dig Dis Sci 1998;43:447-458.
41. Singh GB, Atal CK. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 1986;18:407-412.
42. Stiel D. Exploring the link between gastrointestinal complications and over-the-counter analgesics: Current issues and considerations. Am J Ther 2000;7:91-98.
43. Wang BW, Wu Y, Cao YX. Analgesic and anti-inflammatory effects of maqian bolus. Xi Bei Yao Xue Za Zhi (J Northwest Pharmaceutics) 1994:9:159-161.
44. Wang CY, Ji SY, Wang R. The examples in clinical application of Huo Luo Xiao Ling Dan. Zhong Yi Yao Xue Bao 2002;30:53.
45. Wei F, Zou S, Young A, Dubner R, Ren K. Effects of four herbal extracts on adjuvant-induced inflammation and hyperalgesia in rats. J Altern Complement Med 1999;5:429-436.
46. WHCCAMP Final Report. White House Commission on Complementary and Alternative Medicine Policy. 2002. Available at: www.whccamp.hhs.gov/ finalreport.html, accessed January 9, 2005.
47. Woolf CJ, Allchorne A, Safieh-Garabedian B, Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br J Pharmacol 1997;121:417-424.
48. Xu JY, Zhou YF, Li GL. Analgesic effect of Aqitie. China J Med Drug (Zhong Guo Yi Yao Xue Bao) 1997;12:11-13.
49. Yu QH. The dose exchange between human and experimental animals. In: Chen C (ed.) Research Methodology on Pharmacology of Chinese Materia Medica. Beijing: People's Health Press, 2000:1103-1105.
50. Zhang RX, Zhang R, Wang R,Cheng JY, Qiao JT. Effects of descending inhibitory systems on the c-fos expression in the rat spinal cord during formalin-induced noxious stimulation. Neurosci 1994;58:299-304.
51. Zhang XC. Records of Heart-felt Experiences in Medicine with the Reference to the West (Yi Xue Zhong Zhong Can Xi Lu), 1918 [in Chinese].
52. Zhen FM, Guo LW, Bian HM, Jin SL. Effect of four preparation techniques on analgesic and anti-inflammatory effect of olibanum. J Nanjing Univ TCM 2003;19:213-214.
53. Zhou F, Fang H. Experimental studies on pharmacodynamics of Fufang Sanqi Jiu. Shi Zhen Guo Yi Guo 2003;14:598-599.
54. Zhou JY, Cui R. Chemical components of Boswellia carterii. Yao Xue Xue Bao 2002;37:633-635.
55. Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Amsterdam: Harwood Academic Publishers, 1998:27-32.
56. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-110.